Luhmann H J
Department of Neurophysiology, University of Düsseldorf, Germany.
Prog Neurobiol. 1996 Feb;48(2):131-66. doi: 10.1016/0301-0082(95)00042-9.
Cortical structures are often critically affected by ischemic and traumatic lesions which may cause transient or permanent functional disturbances. These disorders consist of changes in the membrane properties of single cells and alterations in synaptic network interactions within and between cortical areas including large-scale reorganizations in the representation of the peripheral input. Prominent functional modifications consisting of massive membrane depolarizations, suppression of intracortical inhibitory synaptic mechanisms and enhancement of excitatory synaptic transmission can be observed within a few minutes following the onset of cortical hypoxia or ischemia and probably represent the trigger signals for the induction of neuronal hyperexcitability, irreversible cellular dysfunction and cell death. Pharmacological manipulation of these early events may therefore be the most effective approach to control ischemia and lesion induced disturbances and to attenuate long-term neurological deficits. The complexity of secondary structural and functional alterations in cortical and subcortical structures demands an early and powerful intervention before neuronal damage expands to intact regions. The unsatisfactory clinical experience with calcium and N-methyl-D-aspartate antagonists suggests that this result might be achieved with compounds that show a broad spectrum of actions at different ligand-activated receptors, voltage-dependent channels and that also act at the vascular system. Whether the same therapy strategies developed for the treatment of ischemic injury in the adult brain may be applied for the immature cortex is questionable, since young cortical networks with a high degree of synaptic plasticity reveal a different response pattern to hypoxic and ischemic insults. Age-dependent molecular biological, morphological and physiological parameters contribute to an enhanced susceptibility of the immature brain to these noxae during early ontogenesis and have to be investigated in more detail for the development of adequate clinical therapy.
皮质结构常受到缺血性和创伤性损伤的严重影响,这些损伤可能导致短暂或永久性的功能障碍。这些障碍包括单个细胞的膜特性变化以及皮质区域内和之间突触网络相互作用的改变,包括外周输入表征中的大规模重组。在皮质缺氧或缺血发作后的几分钟内,可以观察到显著的功能改变,包括大量膜去极化、皮质内抑制性突触机制的抑制和兴奋性突触传递的增强,这些可能代表了诱导神经元过度兴奋、不可逆细胞功能障碍和细胞死亡的触发信号。因此,对这些早期事件进行药理学干预可能是控制缺血和损伤引起的功能障碍以及减轻长期神经功能缺损的最有效方法。皮质和皮质下结构继发性结构和功能改变的复杂性要求在神经元损伤扩展到完整区域之前进行早期且有力的干预。钙拮抗剂和N-甲基-D-天冬氨酸拮抗剂的临床经验并不理想,这表明使用在不同配体激活受体、电压依赖性通道以及对血管系统也有作用的具有广泛作用谱的化合物可能会取得更好的效果。针对成人大脑缺血性损伤开发的相同治疗策略是否适用于未成熟皮质尚存在疑问,因为具有高度突触可塑性的年轻皮质网络对缺氧和缺血性损伤表现出不同的反应模式。年龄相关的分子生物学、形态学和生理学参数导致未成熟大脑在早期发育过程中对这些有害物质的易感性增强,为了开发适当的临床治疗方法,必须对这些参数进行更详细的研究。